Rotation vs. Risk Sentiment

Rotation vs. Risk Sentiment

Equities 5 minutes to read

Summary:  We discuss the ongoing reflation thematic and associated rotation that is playing into recent market moves.


Despite the sell-off in tech grabbing headlines, under the hood the reflation rotation is firmly intact. Global growth continues to rebound and breakevens are at the highest level since pre- 2008 as vaccination programmes roll out, COVID-19 retreats, restrictions are wound back, and economic activity normalises.

As economies reopen, the pickup in growth alongside recovery in business conditions and confidence as activity normalises is one of the pillars of support for ongoing recoveries, a synchronised global growth upswing and sustained gains for reflation trades. In fact, the reflationary pulse is so strong investors are increasingly concerned about inflationary pressures making for a fragile equity environment as global bond yields rise. Yields will continue to rise with global reflation, but given their low base, and the strong outlook for growth, equity prices can rise in tandem, primarily for sectors of the market most leveraged to ongoing economic recoveries – commodities, materials, financials, industrials etc. and hitting speculative portions of the market like bubble stocks that rely on low rates to propel their infinitesimal valuations. The higher that yields go, the more pressure is on that rotation. Also expect the rotation from “Covid winners” to “Covid losers” to continue along with the shift from growth to value plays as the economic cycle accelerates out of the crisis trough.

The economic recovery has begun, and the inflation uptick is already here. Recent PMI surveys point to inflationary pressures with supply bottlenecks, increasing input costs and demand rebounding. Commodity prices continue to push higher. And these pressures are feeding through to survey data – ISM, global PMIs, China PPI etc. – soon to be visible in headline CPI indices. In addition, consumers are ready to spend, Covid fatigue has set in and the pent-up demand bounce back is kicking in, further fuelling the price pressures already creeping through the system. Disposable income has risen during the pandemic and we are looking at an aggressive demand bounce back accompanying vaccine rollout, intensified by Covid fatigue. In the US household spending expectations are at a 4-year high against a backdrop of elevated savings. In Australia, the better-than-expected 4Q GDP was led by households spending savings built up from stimulus payments/lockdown and spending up on discretionary items.

As we have posited previously, the reflation rotation is on as economic recoveries resume into Q1 against the backdrop of ongoing fiscal spending and vaccine rollouts with inflationary pressures rearing their head.

Toward the end of last year we wrote - for pro-cyclical stocks there is more room for normalisation and these sectors can look past immediate risks … Rendering opportunities to play the ‘economic reopening’ and cyclical rotation … (industrials, materials, miners, travel and leisure, energy etc., emerging markets - favoured EWZ, EWW, THD, small caps - IWM) Providing a relative opportunity for outperformance …Relative togrowth/tech and momentum names that have front-loaded several quarters of gains. The best opportunities in the coming months are likely to come from those most leveraged to economic activity normalising that have low expectations like industrials, materials, travel and leisure, and energy. In addition, commodities with the trifecta of drivers supporting the outlook through to 2021 - Supply deficits, policy tailwinds from infrastructure spending and green electrification trends and on the macro side tailwinds from a weaker USD and rising inflation.

Looking at the sectors, energy has outperformed tech by almost 40% YTD. The Dow Jones closed at record high this week vs. the Nasdaq which has suffered a more than 10% drawdown of recent ATHs. This as investors pivot away from tech during recovery phase of cycle, toward cyclicals, the new market stalwarts. Economic optimism works against the long duration tech trades and supports pro-cyclical allocations. The SPX can return to all-time highs but with a different composition – a changing of the guard. SPX breadth is at the highest level since November and without Facebook, Amazon, Apple, Microsoft and Tesla, the index would’ve been up by 0.2% overnight, instead of closing lower.

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Saxo Markets
Most of our staff in Singapore are working from home to help limit the spread of the coronavirus. We remain at your service on the details below. Thank you for your understanding.

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.